Towards Healthcare
Antibody Therapy Market Soars USD 314.64 Billion in 2025 at 13.08% CAGR

Antibody Therapy Market 2025 is Accelerated by AI-Enhanced Discovery and Trials

Based on market forecasts, the global antibody therapy market, projected at USD 278.25 billion in 2024, is expected to reach USD 951.24 billion by 2034, growing at a CAGR of 13.08% over the forecast period. The antibody therapy market is expanding due to rising chronic diseases as well as growing advances in antibody discovery. North America led the market due to the presence of the advanced healthcare sector.

  • Insight Code: 5850
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The antibody therapy market is projected to reach USD 951.24 billion by 2034, growing at a CAGR of 13.08% from 2024 to 2034.

North America is currently leading the antibody therapy market due to the presence of the advanced healthcare sector.

The antibody therapy market includes six segments such as by type of antibody, by therapy area, by mechanism of action, by route of administration, by end-user, and by region. 

Some key players include Takeda Pharmaceuticals, Bristol-Myers Squibb, Novartis AG, and Merck & Co., Inc.

Key trends include innovation in anti-SARS-CoV-2 spike protein monoclonal antibody (mAb) therapy and rising bispecific antibody use for transforming cancer care.

Diseases such as cancer, autoimmune disorders, infectious diseases, and inflammatory conditions are treated with the use of antibody therapy.

Growing advancements in antibody discovery are the factor that drives the market.

American Cancer Society, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.